The company is also launching the preparation of a Phase 111 clinical trial in collaboration with Quebec’s leading medical cannabis clinic, Santé Cannabis.
More information can be found here.
Tetra-Bio Pharma is a multi-subsidiary publicly traded company engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.
The Ontario-based company was in the news recently when it and and Aphria Inc. (TSX: V.APH, OTCQB: APHQF, Forum) announced plans for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.
Tetra and Aphria will enter into a joint supply agreement, the companies said in a press release.
Full Disclosure: Tetra Bio-Pharma Inc. is a paid client of Stockhouse Publishing.